Researchers Create Telomouse Model for Aging and Cancer Studies

A mouse model with human-length telomeres has been developed. Dubbed the Telomouse, it was designed to facilitate the in-depth exploration of aging and cancer. This achievement is the result of subtle genetic modifications in standard laboratory mice, Mus musculus, to align their telomeres more closely with those of humans. Telomeres play a crucial role in maintaining genetic integrity, supporting healthy aging, and reducing cancer risks. However, the significant difference in telomere length between standard lab mice and humans has posed challenges in using mouse models to understand the impact of telomeres on human aging and cancer.

The Telomouse model, developed by researchers from Hebrew University and the University of Pennsylvania Perelman School of Medicine, involved transferring a minor genetic variation from a mouse species, M. spretus, with naturally shorter telomeres. The researchers focused on a key protein, RTEL1, and found that this subtle genetic modification enabled the production of mice with telomeres of human length. These Telomice displayed robust health and reproductive capabilities.

As part of the study, described in a recent Nature Communications paper, the team also developed a method called NanoTelSeq for precise measurement of individual telomeres, particularly the shortest telomeres, which have a significant influence on cellular function and fate. NanoTelSeq employs nanopore sequencing, and has the potential to evaluate telomeric health in samples from both healthy individuals and patients with cancers and aging-related diseases.

According to the team, the Telomouse model and NanoTelSeq method will contribute to a deeper understanding of the interplay between telomeres, cancer, and the aging process. These insights have the potential to lead to innovative approaches for combating cancer and promoting the well-being of aging individuals, marking a significant milestone in the field of aging and cancer research.